Analysts name 2 excellent ASX 200 shares to buy

Here are two ASX 200 shares analysts rate as buys…

| More on:
a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.

Image source: Getty Images

While recent volatility has been disappointing, it may have created attractive entry points for some ASX 200 shares.

Two such shares are listed below. Here’s why analysts see a lot of value in them at current levels:

CSL Limited (ASX: CSL)

The first ASX 200 share to look at is CSL. It is one of the world’s leading biotherapeutics and vaccine companies.

CSL has a world class portfolio of products that are used around the world to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders.

But management isn’t resting on its laurels. It is investing ~US$1 billion a year (and growing) into research and development and is in the process of making a major acquisition. The latter will add treatments for iron deficiency, nephrology and cardio-renal through the acquisition of Vifor Pharma for $17 billion.

The team at Citi is positive on its growth outlook over the coming years. For example, this year the broker is forecasting a net profit of US$3,158 million. It expects this to then grow to US$4,689 million by FY 2024.

Citi currently has a buy rating and $340.00 price target on the company’s shares. This compares to the latest CSL share price of $264.52.

REA Group Limited (ASX: REA)

Another ASX 200 share to look at is REA Group. It is best known as the digital advertising company that operates Australia’s leading property website, realestate.com.au.

But there’s more to REA than just the realestate.com.au website. It also owns and operates a number of complementary businesses in the Australian market and internationally. These include property listing websites and mortgage broking.

All in all, together with new revenue streams, its good cost control, and a strong housing market, REA appears well-placed for growth over the coming years.

Goldman Sachs is confident in its growth outlook. It is forecasting a net profit of $388 million in FY 2022, $445 million in FY 2023, and then ultimately $510 million in FY 2024.

In light of this, the broker has put a buy rating and $193.00 price target on REA’s shares. This compares to the current REA share price of $146.83.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has recommended REA Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

a businessman in a suit tries to forge ahead but is carrying a rope attached to a large anchor that is stuck in the ground against a background of muted sky and barren earth.
Broker Notes

What’s dragging on the Wesfarmers share price on Monday?

We check what one leading broker has to say about the retail giant's prospects.

Read more »

Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory
Broker Notes

Where next for the CSL share price?

CSL shares could be heading higher according to one leading broker...

Read more »

Woman on her laptop thinking to herself.
Broker Notes

2 ASX All Ordinaries shares top brokers rate as buys

Here are the latest buy-rated shares from two leading brokers.

Read more »

A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.
Broker Notes

Brokers: 2 ASX 200 shares that could be top buys for growth

Brokers think these ASX 200 shares with growth potential could be leading opportunities.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys...

Read more »

outperforming asx share price represented by row of white eggs with cartoon sad faces with one gold egg with happy face and crown
Broker Notes

This is the best ASX bank share to buy in a rising rate environment: Citi

Only one major bank is sticking to its cost-savings goals, according to the broker.

Read more »

A woman sits at her computer in deep contemplation with her hand to her chin and seriously considering information she is receiving from the screen of her laptop regarding the Xero share price
Broker Notes

Is the Fortescue share price cheap after dropping 10% in a month?

We check what brokers have to say on the iron ore giant.

Read more »

A business man in soft-focus holds two fingers in the air in the foreground of the shot as he stands smiling in the background against a clear sky.
Broker Notes

Buy these 2 ASX shares on sale right now: top broker

A top broker has revealed two ASX shares which have fallen heavily but look like good buys.

Read more »